Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Influenza and Other Respiratory Viruses|October 11, 2025
Clinical and Socioeconomic Burden of RSV Infections Among Older Adults in Primary Care: An International Prospective Cohort StudySarah F Hak, Joanne G Wildenbeest, Sara Bracaloni, et al.
The Lancet Regional Health. Europe|July 23, 2024
Healthcare costs related to respiratory syncytial virus in paediatric intensive care units in the Netherlands: a nationwide prospective observational study (the BRICK study)Emily W E M Phijffer, Joanne G Wildenbeest, Carole N M Brouwer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 13, 2023
Soluble Signal Inhibitory Receptor on Leukocytes-1 Is Released from Activated Neutrophils by Proteinase 3 CleavageHelen J von Richthofen, Geertje H A Westerlaken, Doron Gollnast, et al.
The Journal of Infectious Diseases|June 24, 2022
Decreased Antibody Response After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Patients With Down SyndromeBianca M M Streng, Marin Bont, Eveline M Delemarre, et al.
The Journal of Infectious Diseases|April 1, 2020
Low Sensitivity of BinaxNOW RSV in InfantsRoy P Zuurbier, Louis J Bont, Annefleur C Langedijk, et al.
The Journal of Infectious Diseases|August 15, 2020
Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in EuropeJoanne G Wildenbeest, Roy P Zuurbier, Koos Korsten, et al.
The Pediatric Infectious Disease Journal|March 31, 2018
Antibiotic Overuse in Children with Respiratory Syncytial Virus Lower Respiratory Tract InfectionChantal B van Houten, Christiana Naaktgeboren, Brigitte J M Buiteman, et al.
The Lancet. Respiratory Medicine|November 13, 2022
The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort studyJoanne G Wildenbeest, Marie-Noëlle Billard, Roy P Zuurbier, et al.
Pageof 13